We are live on ! Find out more
NTLA icon

Intellia Therapeutics
NTLA

140 hedge funds and large institutions have $569M invested in Intellia Therapeutics in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 35

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

4% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 24

1.26% less ownership

Funds ownership: 93.33% → 92.06% (-1.3%)

2% less funds holding

Funds holding: 143 → 140 (-3)

15% less capital invested

Capital invested by funds: $669M → $569M (-$100M)

33% less call options, than puts

Call options by funds: $1.12M | Put options by funds: $1.67M

Holders
140
Holders Change
-3
Holders Change %
-2.1%
% of All Funds
3.08%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
46
Reduced
35
Closed
24
Calls
$1.12M
Puts
$1.67M
Net Calls
-$548K
Net Calls Change
+$567K

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$20.2M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.42M
3
IC
Ikarian Capital
Texas
+$2.49M
4
BlackRock
BlackRock
New York
+$1.98M
5
JP Morgan Chase
JP Morgan Chase
New York
+$1.32M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$4.09M
2
N
Nuveen
North Carolina
-$4.08M
3
AG
Artal Group
Luxembourg
-$2.93M
4
Two Sigma Investments
Two Sigma Investments
New York
-$1.67M
5
3C
361 Capital
Colorado
-$1.39M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
101
Ameritas Investment Company
Nebraska
$31K +$35K +2,600 New
Canada Life
102
Canada Life
Manitoba, Canada
$29K – – –
KFS
103
Kelly Financial Services
Massachusetts
$28.1K – – –
BEI
104
Benjamin Edwards Inc
Missouri
$22K -$822 -61 -3%
PFO
105
Pathstone Family Office
New Jersey
$22K – – –
FMTCOCP
106
Farmers & Merchants Trust Co of Chambersburg PA
Pennsylvania
$20K +$22.2K +1,650 New
Walleye Capital
107
Walleye Capital
New York
$18K -$15K -1,112 -43%
WEC
108
Winslow Evans & Crocker
Massachusetts
$18K +$18.8K +1,392 New
APA
109
American Portfolios Advisors
New York
$17.1K +$14K +1,041 +290%
AWM
110
AllSquare Wealth Management
New York
$13K – – –
KBC Group
111
KBC Group
Belgium
$12K – – –
VFA
112
Valeo Financial Advisors
Indiana
$10K – – –
GWM
113
Geneos Wealth Management
Colorado
$10K +$12.4K +917 New
CFA
114
Carroll Financial Associates
North Carolina
$9K – – –
APWM
115
Atlas Private Wealth Management
New York
$8K – – –
BFEC
116
Benjamin F. Edwards & Company
Missouri
$7K – – –
FHA
117
Flagship Harbor Advisors
Massachusetts
$6K +$4.45K +330 +220%
WT
118
Whittier Trust
California
$5K – – –
S
119
SignatureFD
Georgia
$5K +$4.43K +329 +319%
SPIA
120
Steward Partners Investment Advisory
New York
$4K -$6.74K -500 -56%
Daiwa Securities Group
121
Daiwa Securities Group
Japan
$4K – – –
RWA
122
Ropes Wealth Advisors
Massachusetts
$4K – – –
SIA
123
SeaBridge Investment Advisors
New Jersey
$4K – – –
RE
124
RBC Europe
United Kingdom
$3.49K – – –
Bank of Montreal
125
Bank of Montreal
Ontario, Canada
$3K -$67.3K -4,999 -95%
3 4
5
6 7

NTLA Hedge Fund Activity: Q1 2020 in Review

140 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Intellia Therapeutics (NTLA) for Q1 2020, worth a combined $569M — down 15% from $669M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of NTLA and 23 opened new positions — a net loss of 1 holder — while 35 trimmed existing stakes and 46 added.

The largest buyer was ARK Investment Management, adding an estimated $20.2M. The largest seller was Morgan Stanley, cutting an estimated $4.09M.

  • 140 institutional investors held Intellia Therapeutics (NTLA) as of Q1 2020, down from 143 in Q4 2019.
  • Funds reported $569M of Intellia Therapeutics stock for Q1 2020, down 15% quarter-over-quarter.
  • 23 funds opened new Intellia Therapeutics positions in Q1 2020 and 24 closed out, a net change of -1 holder.
  • The largest Intellia Therapeutics buyer in Q1 2020 was ARK Investment Management, an estimated $20.2M added.
  • The largest Intellia Therapeutics seller in Q1 2020 was Morgan Stanley, an estimated $4.09M sold.

Based on aggregated 13F filings for Q1 2020.